GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Dividend Payout Ratio

Innovative Pharmaceutical Biotech (HKSE:00399) Dividend Payout Ratio : 0.00 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Innovative Pharmaceutical Biotech's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Innovative Pharmaceutical Biotech's Dividend Payout Ratio or its related term are showing as below:


HKSE:00399's Dividend Payout Ratio is not ranked *
in the Retail - Cyclical industry.
Industry Median: 0.42
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2025-03-23), the Dividend Yield % of Innovative Pharmaceutical Biotech is 0.00%.

Innovative Pharmaceutical Biotech's Dividends per Share for the months ended in Sep. 2024 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Innovative Pharmaceutical Biotech Dividend Payout Ratio Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Dividend Payout Ratio Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Innovative Pharmaceutical Biotech Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Innovative Pharmaceutical Biotech's Dividend Payout Ratio

For the Specialty Retail subindustry, Innovative Pharmaceutical Biotech's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Pharmaceutical Biotech's Dividend Payout Ratio Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Innovative Pharmaceutical Biotech's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Dividend Payout Ratio falls into.



Innovative Pharmaceutical Biotech Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Innovative Pharmaceutical Biotech's Dividend Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2024 )/ EPS without NRI (A: Mar. 2024 )
=0/ -0.14
=N/A

Innovative Pharmaceutical Biotech's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ -0.067
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative Pharmaceutical Biotech (HKSE:00399) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Innovative Pharmaceutical Biotech Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech Business Description

Traded in Other Exchanges
N/A
Address
145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.
Executives
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines